UBS Group Cuts Procter & Gamble (NYSE:PG) Price Target to $189.00

Procter & Gamble (NYSE:PG) had its price target trimmed by UBS Group from $196.00 to $189.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other equities analysts also recently commented on the stock. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a research note on Monday, September 30th. Morgan Stanley increased their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Piper Sandler initiated coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Finally, Evercore ISI increased their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $179.65.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $161.35 on Thursday. The company has a 50 day moving average of $169.19 and a 200-day moving average of $169.38. Procter & Gamble has a 1-year low of $146.28 and a 1-year high of $180.43. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The company has a market cap of $379.98 billion, a PE ratio of 27.82, a price-to-earnings-growth ratio of 3.41 and a beta of 0.45.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the prior year, the firm posted $1.83 EPS. The firm’s quarterly revenue was down .6% on a year-over-year basis. As a group, equities research analysts forecast that Procter & Gamble will post 6.93 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.50%. The ex-dividend date of this dividend is Friday, January 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Insider Transactions at Procter & Gamble

In related news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. This represents a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 75,439 shares of company stock worth $13,317,460 over the last three months. 0.18% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of PG. FCG Investment Co lifted its stake in shares of Procter & Gamble by 7.2% in the fourth quarter. FCG Investment Co now owns 7,418 shares of the company’s stock valued at $1,244,000 after buying an additional 499 shares in the last quarter. Apeiron RIA LLC lifted its stake in shares of Procter & Gamble by 14.2% in the fourth quarter. Apeiron RIA LLC now owns 5,222 shares of the company’s stock valued at $875,000 after buying an additional 651 shares in the last quarter. Secure Asset Management LLC lifted its stake in shares of Procter & Gamble by 28.1% in the fourth quarter. Secure Asset Management LLC now owns 5,083 shares of the company’s stock valued at $852,000 after buying an additional 1,115 shares in the last quarter. Red Door Wealth Management LLC lifted its stake in shares of Procter & Gamble by 2.9% in the fourth quarter. Red Door Wealth Management LLC now owns 52,069 shares of the company’s stock valued at $8,729,000 after buying an additional 1,461 shares in the last quarter. Finally, Madrona Financial Services LLC bought a new position in shares of Procter & Gamble in the fourth quarter valued at $382,000. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.